Sign in: Staff/Students
The University of Liverpool is part of an international research team that will assess whether the blood or plasma of Ebola survivors can be used to treat Ebola patients in West Africa.
The research team will receive over £2million from the European Union (EU) to evaluate the safety and efficacy of blood and plasma donated by people who have recovered from Ebola.
Using blood or plasma from recovered Ebola patients was identified by the World Health Organisation (WHO) as one of the most promising strategies for treating the disease and is a priority for urgent evaluation.
As a result of the current outbreak, there are substantial numbers of Ebola survivors available to donate blood. Survivors of Ebola have antibodies in their blood which have developed specifically to deal with the virus.
The use of convalescent blood and plasma will be trialled in Guinea, West Africa, in November by a consortium led by Dr Calum Semple from the University of Liverpool’s Institute of Child Health based at Alder Hey Children’s Hospital and Dr Johan van Griensven of the Prince Leopold Institute of Tropical Medicine (ITM) Antwerp.
Dr Semple said: “Convalescent plasma therapy is a medical intervention which has been used for a long time to treat other diseases safely. We want to find out whether the Ebola plasma will work, is safe and can be used to reduce the number of deaths in the present outbreak.”
Johan van Griensven added: “Ebola survivors contributing to curb the epidemic by donating blood could reduce fear of the disease and improve their acceptance in the communities.”
The project is funded by the European Union and supported and guided by the WHO, the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) with additional support from The Wellcome Trust enabling unparalleled international collaboration across the public, private and not-for-profit sectors to tackle the Ebola emergency.
The research consortium involves the Institute of Tropical Medicine in Antwerp, the London School of Hygiene and Tropical Medicine, the University of Oxford, Aix-Marseille University, the French Blood Transfusion Service, Institute Pasteur, Institute National de la Sante et de La Recherche Medicale (INSERM), the National Blood Transfusion Centre in Conakry (Guinea), the Institut National de Recherche Biomédicale in Kinshasha (DRC), and the Belgian Red Cross.
You must be logged in to post a comment.
All recent news
Study outlines mechanism behind rare blood clots linked to COVID-19 vaccine
Sex, drugs and rock’n’roll’? Link between taking illegal drugs and non-traditional sex found
Summer Term Events Programme – What’s on during week 2
Introducing Inspired Futures 2021
Take part in the Merseyside Bird Race – 22-23 April
Our paper on immune responses to COVID vaccine (mostly Pfizer) in 237 healthcare workers, 124 #SARSCoV2 naïve and 113 previously infected, from the PITCH consortium @pitchstudy is out as a pre-print today.
See if you can spot us in the new @NetflixUK series, The Irregulars! 📽️
Our @VictoriaGallery appears in it, as well as other locations across the city including St George’s Plateau, the Palm House in Sefton Park and Falkner Street in the Georgian Quarter.
Professor Michael Parkinson CBE, author of 1985's Liverpool on the Brink, and Liverpool Beyond the Brink in 2019, analyses the Caller Report, the Gov's Best Value inspection into Liverpool City Council